GRM1 and melanoma: This second transgenic line displays similar tumor onset and progression as the first one, confirming that the aberrant expression of mGluR1 in melanocytes was sufficient to promote melanocyte hyperplasia and transformation into malignant melanoma, similar to human melanoma development [108,111,112].